Regeneron Pharmaceuticals REGN Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's total costs & expenses?
- Regeneron Pharmaceuticals (REGN) reported total costs & expenses of $2.96B in Q1 2026.
- How has Regeneron Pharmaceuticals's total costs & expenses changed year-over-year?
- Regeneron Pharmaceuticals's total costs & expenses increased by 21.6% year-over-year, from $2.44B to $2.96B.
- What is the long-term trend for Regeneron Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's total costs & expenses has grown at a 10.9% compound annual growth rate (CAGR), from $7.12B to $10.77B.